Patient With Unresectable Cholangiocarcinoma Treated With Radiofrequency Hyperthermia in Combination With Chemotherapy: A Case Report
/in Gallbladder Cancer, Hyperthermia, International Publications /von 2017-07-26 / Integr Cancer Ther 2018 06;17(2):558-561Retrospective Clinical Study of Advanced Pancreatic Cancer Treated With Chemotherapy and Abdominal Hyperthermia
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2017-07-25 / J Glob Oncol 2018 Sep;4:1-4Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma
/in Brain Tumors in Children, International Publications /von 2017-07-25 / Front Pharmacol 2017;8:495Recent developments in immunotherapy of acute myeloid leukemia
/in Acute Leukemia, Dendritic Cells, International Publications /von 2017-07-25 / J Hematol Oncol 2017 07;10(1):142Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade
/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2017-07-19 / Int J Cancer 2017 11;141(9):1891-1900Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
/in International Publications, Newcastle Disease Virus /von 2017-07-15 / Cancer Immunol. Immunother. 2017 Oct;66(10):1249-1264IOZK Artikel im International Journal of Molecular Sciences von Prof. Schirrmacher über die Rolle des Newcastle Disease Virus im Rahmen der Tumorimpfung,
/in IOZK In der Presse, IOZK Veröffentlichungen /von IOZKThe effect of thermal dose on hyperthermia-mediated inhibition of DNA repair through homologous recombination
/in Hyperthermia, International Publications /von 2017-07-04 / Oncotarget 2017 Jul;8(27):44593-44604
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution